trending Market Intelligence /marketintelligence/en/news-insights/trending/10ST2HkgXKRjoKfnuU8ACw2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

ContraVir implements 1-for-70 reverse stock split


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Climate Credit Analytics: Linking climate scenarios to financial impacts


Global M&A Infographic Q1 2021


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

ContraVir implements 1-for-70 reverse stock split

ContraVir Pharmaceuticals Inc. implemented a 1-for-70 reverse stock split of its common shares, effective May 31.

The Edison, N.J.-based biopharmaceutical company is undertaking the transaction to regain compliance with Nasdaq Capital Market's minimum bid price listing requirement.

The company's common shares will start trading on a split-adjusted basis on June 3 under the existing symbol CTRV.

ContraVir's board in March approved the reverse stock split, which was later endorsed by a majority of the company's shareholders May 2.